PainReform Ltd
NASDAQ:PRFX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
PainReform Ltd
NASDAQ:PRFX
|
IL |
|
Talbros Engineering Ltd
BSE:538987
|
IN |
|
ZheJiangTailin Bioengineering Co Ltd
SZSE:300813
|
CN |
|
Aya Gold & Silver Inc
TSX:AYA
|
CA |
|
US Masters Residential Property Fund
ASX:URF
|
AU |
|
NFC Indonesia Tbk PT
IDX:NFCX
|
ID |
|
R
|
Rasan Information Technology Company SCJSC
SAU:8313
|
SA |
|
Zhongtai Securities Co Ltd
SSE:600918
|
CN |
|
R
|
Richmond Mutual Bancorporation Inc
NASDAQ:RMBI
|
US |
|
SG Fleet Group Ltd
ASX:SGF
|
AU |
|
Dev Clever Holdings PLC
LSE:DEV
|
UK |
|
B
|
Beneficient
NASDAQ:BENF
|
US |
|
Neovasc Inc
TSX:NVCN
|
CA |
|
G
|
Goldenbridge Acquisition Ltd
NASDAQ:SDA
|
HK |
|
Le Saunda Holdings Ltd
HKEX:738
|
HK |
|
L
|
Lithium Energi Exploration Inc
XTSX:LEXI
|
CA |
|
noco-noco Inc
OTC:NCNCF
|
SG |
|
Astrakhanskaya Energosbytovaya Kompaniya PAO
MOEX:ASSB
|
RU |
|
Predator Oil & Gas Holdings PLC
LSE:PRD
|
JE |
|
S
|
Suzhou Xianglou New Material Co Ltd
SZSE:301160
|
CN |
|
Vitreous Glass Inc
XTSX:VCI
|
CA |
|
Multitude AG
XETRA:MULT
|
CH |
|
Whirlpool SA
BOVESPA:WHRL4
|
BR |
|
Genasys Inc
NASDAQ:GNSS
|
US |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of PRFX.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
PRFX Competitors Multiples
PainReform Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IL |
|
PainReform Ltd
NASDAQ:PRFX
|
1.8m USD | 0 | -0.1 | 0.1 | 0.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
847.5B USD | 13 | 41.1 | 27.7 | 29.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
576.1B USD | 6.1 | 21.5 | 14.9 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.3 | 11.5 | 12.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
294.3B USD | 4.5 | 16.1 | 10 | 12.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.3B CHF | 5.2 | 21.1 | 13 | 16.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.5B GBP | 5.1 | 29.1 | 16.1 | 22.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.3 | 10 | 7.4 | 8.7 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
156.8B USD | 2.5 | 20.2 | 7.7 | 10.3 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.6B USD | 2.5 | 17 | 7.2 | 8.8 |